$IOBT: Steve Cohen (Point72) Just Dropped a 13G – 5.6% Stake + Short Interest Spiking 📈🚀

What’s up everyone, keeping an eye on IO Biotech ($IOBT) as it’s showing some major institutional heat and potential squeeze signals this week.

The Whale: Point72 (Steve Cohen) Enters the Chat:

A Schedule 13G was just filed (Feb 5, 2026) showing that Point72 Capital Advisors (Steve Cohen's fund) has officially taken a 5.6% passive stake in IOBT.

• Total Shares Owned: 4,027,112

• The Signal: Point72 is one of the smartest "smart money" players in the biotech space. When they drop a 13G on a stock trading under $0.50, it usually means they see a massive valuation gap or a major clinical catalyst on the horizon.

The Squeeze Setup: Short Interest +47%:

The bears have been piling in, but they might have just cornered themselves. According to the latest data:

• Short Interest Change: Up a massive 47.2% recently.

• Short % of Float: Currently sits between 4.4% and 7.1%.

• Days to Cover: 4.2 Days. (This is the key—if volume spikes, it will take shorts nearly a full trading week to exit their positions).

• Borrow Fee: Rates have been volatile, hitting as high as 35% in recent days.

🧪 Why IOBT? (The Fundamentals):

• Sector: In Vitro/In Vivo Diagnostics & Oncology.

• Price Target: Even though some analysts trimmed targets recently, the average 1-year target still sits around $1.66. We are currently trading at a massive discount to that (\~$0.28 range).

• Recent News: The company announced an "exploration of strategic alternatives" in late January. In penny stock speak, that often means they are looking for a buyout or a major partnership.

Point72 just disclosed a 5.6% stake, short interest is jumping, and the stock is trading at a fraction of its analyst price targets. With a 4.2-day cover ratio, thus could trigger a massive "short-covering" rally.

Disclaimer: Not financial advice. I’m just a guy who likes looking at SEC filings. Do your own DD.